TAF
VTAE

Tredje AP-fonden’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Tredje AP-fonden’s Portfolio VTAE Stock Details VTAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-22,000
Closed -$848K – 302
2015
Q2 		$848K Buy
+22,000
New +$299K 0.07% 272

Other funds holding VTAE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Tredje AP-fonden's VTAE Position: Q3 2015 in Review

Tredje AP-fonden sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q3 2015, closing a stake of 22,000 shares — an estimated $848K sold.

Tredje AP-fonden first reported a position in VTAE in Q2 2015 and held it in 1 quarter. The position peaked at $848K in Q2 2015. 70 funds tracked by Wall St. Rank hold VTAE as of Q3 2015.

  • Tredje AP-fonden reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q3 2015 after selling out during the quarter.
  • Tredje AP-fonden sold 22,000 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q3 2015, an estimated $848K.
  • Tredje AP-fonden first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q2 2015 and held it in 1 quarter.
  • Tredje AP-fonden's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $848K in Q2 2015.
  • 70 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q3 2015.

Based on Tredje AP-fonden's 13F filing for Q3 2015, filed 10 Nov 2015.